- 询价
- Nebulabio
- 中国
- NBL-291198
- 2026年01月04日
企业认证
相关产品推荐更多 >
PRH1蛋白 | Human PRH1 Protein,17-122aa
询价
重组人EDNRA蛋白 | Recombinant Human EDNRA Protein, 20-80aa, His-tag, GST-tag
询价重组人MARK1蛋白 | Recombinant Human MARK1 Protein, 58-371aa, His-tag
询价
CD3E&CD3G/CD3 epsilon&CD3 gamma蛋白 | Biotinylated Human CD3E&CD3G/CD3 epsilon&CD3 gamma, Avi-hFc-tag
询价
重组人HAMP蛋白 | Recombinant Human HAMP Protein, 25-84aa, His-tag
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保质期：
见COA
- 库存：
大量
- 供应商：
北京辰辉创聚生物技术有限公司
- 规格：
100ug; 500ug; 1mg; Bulk
| 产品信息
品名：NebuSelect™ Recombinant Human CD221/IGF1R Protein
中文名称：重组人CD221, IGF1R蛋白
别名：CD221, IGF1R
货号：NBL-291198
品牌：Nebulabio
规格：100UG；1MG；Bulk
| 产品描述
NebuSelect™ Recombinant Human CD221/IGF1R Protein (Cat# NBL-291198) is expressed in - with His tag. This recombinant protein is of high purity, verified to be greater than 90% by SDS-PAGE. Endotoxin levels are less than 1 EU/µg, as determined by the LAL (Limulus Amebocyte Lysate) assay.
| 产品属性
Species:Human
Expression System:E. coli
Molecular Weight:see COA
Target Name:CD221, IGF1R
Purity:>90% by SDS-PAGE.
Formulation:See COA
Endotoxin:＜1 EU/ug(LAL Method)
Storage:4°C for short term. -20°C for long term.
For Research Use Only!
To get more information, please contact us freely.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验蛋白分离纯化概述（An overview of protein isolation）
Isolating a protein may be compared to playing a game of golf. In golf, the player is faced with a series of problems, each unique and yet similar to problems previously encountered. In facing each problem the player must analyse
网络 四、膜辅蛋白（CD46） 膜辅蛋白（membrane cofactor protein,MCP）由Cole等（1985）应用C3b亲和层析在外周血淋巴细胞上发现的一种膜蛋白。由于其奇特的电泳特征，起初被命名为gp45-70，但进一步研究发现，它对I因子介导的对C3b和C4b的裂解有辅助活性，故更命为MCP。鉴于MCP
Methods for Human CD8+ T Lymphocyte Proteome Analysis
T lymphocytes, including cytotoxic CD8+ T cells, are important cells involved in immunology, as they can destroy infected or tumor cells. We describe here a detailed protocol starting from CD8+ T lymphocytes isolation for T cell culture followed
技术资料暂无技术资料 索取技术资料
